J. Thomas Rosenthal, M.D.

Bio from 8th Annual Healthcare Symposium

J. Thomas Rosenthal, M.D. Associate Vice Chancellor, David Geffen School of Medicine at UCLA

Dr. Rosenthal joined the faculty of UCLA School of Medicine in 1986 as Associate Professor of Urology and Director of Renal Transplantation. Under Dr. Rosenthal’s leadership, the Renal Transplant program tripled in size while maintaining the highest graft survival results in the country. Clinical research was developed as an important part of the program, culminating in the program’s receiving NIH funding for participation in the first NIH sponsored clinical trials in transplantation.

In 1990, he was appointed Executive Vice Chairman of the Department of Surgery and Vice Chairman of the Medical Faculty Board. He was responsible for improvements in contracting for specialty services, development of the Department of Surgery practice plan, and for hospital-wide clinical pathway development. In 1995, Dr. Rosenthal was appointed Interim CEO of the UCLA Medical Group, and in 1996 was formally appointed by to be Vice Provost and Director of the Medical Group. As Director of the Medical Group, he provided oversaw development of managed care services, including contracting, quality management, clinical effectiveness, utilization management, and claims. In 1999, Dr. Rosenthal’s duties were expanded to include a role as Chief Medical Office of UCLA Medical Center. This position was created to improve coordination efforts of key services among the Medical Staff, Hospital Systems, and the Medical Group.

In 2003, he moved from clinical enterprise to School of Medicine to become Associate Vice Chancellor responsible for a variety of School functions including affiliate relations and research integrity. He remains Professor of Urology and a member of the renal transplant team.

Bio from 9th Annual Healthcare Symposium

Associate Vice Chancellor, David Geffen School of Medicine at UCLA Dr. Rosenthal joined the faculty of UCLA School of Medicine in 1986 as Associate Professor of Urology and Director of Renal Transplantation. Under Dr. Rosenthal’s leadership, the Renal Transplant program tripled in size while maintaining the highest graft survival results in the country. Clinical research was developed as an important part of the program, culminating in the program’s receiving NIH funding for participation in the first NIH sponsored clinical trials in transplantation. In 1990, he was appointed Executive Vice Chairman of the Department of Surgery and Vice Chairman of the Medical Faculty Board. He was responsible for improvements in contracting for specialty services, development of the Department of Surgery practice plan, and for hospital-wide clinical pathway development. In 1995, Dr. Rosenthal was appointed Interim CEO of the UCLA Medical Group, and in 1996 was formally appointed by to be Vice Provost and Director of the Medical Group. As Director of the Medical Group, he provided oversaw development of managed care services, including contracting, quality management, clinical effectiveness, utilization management, and claims. In 1999, Dr. Rosenthal’s duties were expanded to include a role as Chief Medical Office of UCLA Medical Center. This position was created to improve coordination efforts of key services among the Medical Staff, Hospital Systems, and the Medical Group. In 2003, he moved from clinical enterprise to School of Medicine to become Associate Vice Chancellor responsible for a variety of School functions including affiliate relations and research integrity. He remains Professor of Urology and a member of the renal transplant team.

Bio from 10th Annual Healthcare Symposium

Dr. Rosenthal is a urologist and was formerly the Director of the Kidney Transplant Program at UCLA. His accomplishments included substantial growth in the clinical program, achieving competitive NIH funding for clinical trials in transplantation to UCLA, and ultimately achieving research funding in excess of two million dollars. He received his M.D. from Duke in 1974 and completed his residency at the Lahey Clinic. He previously served as Program Director in Urology at UCLA, Vice-Chair for Clinical Affairs and Executive Vice-Chair in the Department of Surgery at UCLA, and Director of the UCLA Medical Group before assuming his current roles. He is a past officer in a number of transplant societies.

Bio from 11th Annual Healthcare Symposium

Professor, Urology
Chief Medical Officer, UCLA Medical Center
Associate Vice Chancellor, David Geffen School of Medicine at UCLA

Dr. Rosenthal is a urologist and was formerly the Director of the Kidney Transplant Program at UCLA. His accomplishments included substantial growth in the clinical program, achieving competitive NIH funding for clinical trials in transplantation to UCLA, and ultimately achieving research funding in excess of two million dollars. He received his M.D. from Duke in 1974 and completed his residency at the Lahey Clinic. He previously served as Program Director in Urology at UCLA, Vice-Chair for Clinical Affairs and Executive Vice-Chair in the Department of Surgery at UCLA, and Director of the UCLA Medical Group before assuming his current roles. He is a past officer in a number of transplant societies.